Drive Wealth Management LLC purchased a new position in shares of 908 Devices Inc. (NASDAQ:MASS – Free Report) in the 3rd quarter, Holdings Channel reports. The firm purchased 14,350 shares of the company’s stock, valued at approximately $50,000.
Other large investors also recently modified their holdings of the company. Bank of New York Mellon Corp increased its holdings in 908 Devices by 6.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 69,550 shares of the company’s stock worth $358,000 after purchasing an additional 4,212 shares in the last quarter. American Century Companies Inc. increased its stake in shares of 908 Devices by 18.6% in the second quarter. American Century Companies Inc. now owns 33,718 shares of the company’s stock valued at $174,000 after buying an additional 5,295 shares during the period. Vanguard Group Inc. raised its holdings in 908 Devices by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 1,751,102 shares of the company’s stock valued at $13,221,000 after buying an additional 6,772 shares during the last quarter. GAMMA Investing LLC acquired a new stake in 908 Devices during the 2nd quarter worth approximately $48,000. Finally, SG Americas Securities LLC acquired a new position in 908 Devices in the 3rd quarter valued at approximately $36,000. 88.06% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms recently weighed in on MASS. Stifel Nicolaus decreased their price objective on 908 Devices from $17.00 to $6.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Leerink Partnrs downgraded 908 Devices from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 13th. Finally, Leerink Partners reaffirmed a “market perform” rating and issued a $4.00 price objective (down from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th.
908 Devices Trading Down 1.3 %
Shares of MASS opened at $2.36 on Tuesday. The firm’s fifty day simple moving average is $3.40 and its two-hundred day simple moving average is $4.62. 908 Devices Inc. has a 12 month low of $2.19 and a 12 month high of $12.51. The stock has a market capitalization of $82.18 million, a P/E ratio of -1.33 and a beta of 0.98.
908 Devices Profile
908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.
Featured Stories
- Five stocks we like better than 908 Devices
- Stock Splits, Do They Really Impact Investors?
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Technology Stocks Explained: Here’s What to Know About Tech
- Applied Materials Market Capitulates: Now is the Time to Buy
- What Is WallStreetBets and What Stocks Are They Targeting?
- 3 Ultra-High Dividend Yield Stocks for the New Year
Want to see what other hedge funds are holding MASS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for 908 Devices Inc. (NASDAQ:MASS – Free Report).
Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.